IFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC.

Affiliation auteurs!!!! Error affiliation !!!!
TitreIFCT-1003 LADIE trial: Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC.
Type de publicationJournal Article
Year of Publication2015
AuteursMazieres J, Barlesi F, Molinier O, Monnet I, Audigier-Valette C, Besse B, Toffart AClaire, Renault P-A, Masson P, Mennecier B, Fraboulet SMoreau, Hiret S, Westeel V, Dumont P, Cortot AB, Pichon E, Lebitasy MPaule, Morin F, Zalcman G, Interg FCooperativ
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume33
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X